Dr. Kenneth Cowan earned his medical degree and Ph.D. in pharmacology at Case Western Reserve University. After three years of internship and residency in internal medicine at the University of Texas Southwestern Affiliated Hospitals, Dr. Cowan joined the Medicine Branch of the National Cancer Institute in 1978 as a clinical associate. He was made senior investigator in the Clinical Pharmacology Branch in 1982. Since 1988, he has been chief of the Medical Breast Cancer Section, and served a year as acting chief of the Medicine Branch.
Dr. Cowan's research has focused on mechanisms of resistance of human cancer cells to anti-cancer drugs, particularly the regulation of the human multi-drug resistance gene in cancer cell lines. Dr. Cowan will discuss "Transfer of Multidrug-Resistant Gene (MDR1) into Hematopoietic Stem Cells: Can MDR1 Protect Chemotherapy Patients from Hematopoietic Toxicity?"
Dr. Robert Danner did his undergraduate work at Johns Hopkins, went to medical school at Cornell, and interned for three years in internal medicine at the New York Hospital, Cornell Medical Center.Dr. Danner first came to NIH in 1983 as a medical staff fellow in critical care and infectious diseases. In 1986, he was appointed senior medical staff fellow in the Clinical Center's Critical Care Medicine Department. Since 1991, he has been chief of the Infectious Diseases Section of that Department. He is also associate clinical professor of medicine in the infectious diseases division at Georgetown University Medical Center. Dr. Danner's research has focused on the role of endotoxin and anti-endotoxin monoclonal antibodies in human septic shock.
His topic is "Vasoregulatory Network in Septic Shock."
 |
Questions about the Clinical Center or CC grand rounds? OCCC@nih.gov Or call: (301) 496-2563 National Institutes of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland 20892 . Last modified 6/98 |